etomidate (Amidate)

From Aaushi
Jump to navigation Jump to search

Introduction

Tradename: Amidate.

Indications

Contraindications

pregnancy category = c

safety in lactation = ?

Dosage

  • induction 0.2-0.6 mg/kg IV over 30-60 seconds
  • may repeat as necessary
  • 10-20 ug/kg/min

Injection: 2 mg/mL (10 mL, 20 mL)

Pharmacokinetics

  • rapidly distributes to body tissue
  • 76% bound to albumin
  • metabolized by liver & in blood
  • eliminated in the urine
  • terminal 1/2life is 2 hours

elimination via liver

1/2life = 2 hours

Adverse effects

Drug interactions

Mechanism of action

More general terms

References

  1. Clinical Guide to Laboratory Tests, 3rd edition, NW Tietz ed, WB Saunders, Philadelphia, 1998
  2. Drug Information & Medication Formulary, Veterans Affairs, Central California Health Care System, 1st ed., Ravnan et al eds, 1998
  3. Kaiser Permanente Northern California Regional Drug Formulary, 1998
  4. 4.0 4.1 Tekwani KL et al. A prospective observational study of the effect of etomidate on septic patient mortality and length of stay. Acad Emerg Med 2009 Jan; 16:11 PMID: https://www.ncbi.nlm.nih.gov/pubmed/19055676
  5. 5.0 5.1 Jabre P et al Etomidate versus ketamine for rapid sequence intubation in acutely ill patients: A multicentre randomised controlled trial. Lancet 2009 Jul 1; <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/19573904 <Internet> http://dx.doi.org/10.1016/S0140-6736(09)60949-1
    Wenzel V and Lindner KH. Best pharmacological practice in prehospital intubation. Lancet 2009 Jul 1; <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/19573905 <Internet> http://dx.doi.org/10.1016/S0140-6736(09)61071-0
  6. 6.0 6.1 Physician's First Watch. Feb 7, 2012 Massachusetts Medical Society McPhee LC et al. Single-dose etomidate is not associated with increased mortality in ICU patients with sepsis: Analysis of a large electronic ICU database. Crit Care Med 2013 Jan 9; PMID: https://www.ncbi.nlm.nih.gov/pubmed/23318491

Database